Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-23-000974
Filing Date
2023-02-15
Accepted
2023-02-15 10:47:57
Documents
1
Period of Report
2023-02-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4751
  Complete submission text file 0001171843-23-000974.txt   6166
Mailing Address C/O RELYPSA, INC. 700 SAGINAW DR. REDWOOD CITY CA 94063
Business Address
Schuetz Thomas J. (Reporting) CIK: 0001591464 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39696 | Film No.: 23634153

Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Issuer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)